February 14, 2022

Dr. Carroll Opinion Piece in the New York Times

Regenstrief Research Scientist Aaron Carroll, M.D., M.S., laid out the challenges faced by people seeking medication to treat COVID-19 in the U.S. health system.

Regenstrief Research Scientist Aaron Carroll, M.D., M.S., laid out the challenges faced by people seeking medication to treat COVID-19 in the U.S. health system.

READ THE NEW YORK TIMES OPINION PIECE
The Latest
Supply, demand, and a growing US kidney transplant waiting list
Influence

Supply, demand, and a growing US kidney transplant waiting list

Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy
Influence

Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

Study reveals gaps in flu treatment for high-risk adults
News

Study reveals gaps in flu treatment for high-risk adults

Regenstrief Institute researcher departs after more than two decades of service 
News

Regenstrief Institute researcher departs after more than two decades of service 

Regenstrief researcher honored by awards from Indiana University and Ball State University
News

Regenstrief researcher honored by awards from Indiana University and Ball State University

Funded internationally, partnership launches free health information training for professionals in low- and middle-income countries
News

Funded internationally, partnership launches free health information training for professionals in low- and middle-income countries